Golestani Clark

Avg. Two Year Performance

No purchase track record
(9%) Avg. Sale Return
(4%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return1%(6%)(3%)(11%)(9%)
Sale Success Rate2 of 42 of 41 of 40 of 41 of 4
Drugs » Drug Manufacturers - Major

EVP & Chief Info Officer:

Holdings: 19.94K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 126.29K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--